--2025/Q1-- / 2.167M--
--2024/Q4-- / 9.870M--
Nov 13, 20242024/Q32.262M / 3.568M--
Aug 7, 20242024/Q23.971M / 3.664M--
May 13, 20242024/Q14.907M / 9.700M--
US Stock MarketDetailed Quotes
CAPR Capricor Therapeutics
- 18.010
- -0.910-4.81%
Trading Nov 21 14:11 ET
818.91MMarket Cap-17656P/E (TTM)
20.030High17.020Low1.87MVolume18.760Open18.920Pre Close33.57MTurnover4.67%Turnover RatioLossP/E (Static)45.47MShares23.40052wk High12.00P/B720.56MFloat Cap2.90052wk Low--Dividend TTM40.01MShs Float7999.998Historical High--Div YieldTTM15.91%Amplitude0.880Historical Low17.982Avg Price1Lot Size
Capricor Therapeutics Key Stats
Capricor Therapeutics Q3 2024 Earnings Date
Currency：USDNov 13, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 3.57M | 2.26M | -1.31M |
| Miss Est. | -42.31% | -63.44% | -36.62% |
| EPS | -0.36 | -0.38 | -0.02 |
| Miss Est. | -43.34% | -52.00% | -6.09% |
Analyst Rating
Nov 18, 2024
Capricor Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Capricor Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data